NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

PATH | NYSE

$13.43 $0.37 | 2.83%
TREND SIGNAL:Signal available — unlock to view |2026-09-04

Company Overview:

Market Cap: $6.81B
Trailing PE: —
FWD PE: —
Payout Ratio (TTM): —
52-Week Range: $9.20 - $19.84

5.5 Year PATH Performance Metrics:

Total Return (with DRIP): -80.5% (-25.74% CAGR)
Total Return (no DRIP): -80.5% (-25.74% CAGR)
Share Price: -80.5% (-25.74% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $1,946
Total Return $ (with DRIP): -$8,054
PATH Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
PATH Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

PATH Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

PATH - Revenue
PATH Revenue CAGR:1Y: 17.32%2Y: 11.74%5Y: 17.57%10Y: 0.00%
PATH - Earnings Per Share (EPS)
PATH EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PATH - Net Income
🔓 See the full chart40% off right now · 7-day free trial
PATH Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PATH - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
PATH EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PATH - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
PATH Free Cash Flow CAGR:1Y: 21.73%2Y: 14.37%5Y: 0.00%10Y: 0.00%
PATH - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
PATH Free Cash Flow / Share CAGR:1Y: 27.51%2Y: 19.33%5Y: 0.00%10Y: 0.00%
PATH - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
PATH Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PATH - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
PATH Gross Profit CAGR:1Y: 16.63%2Y: 10.59%5Y: 20.00%10Y: 0.00%
PATH - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
PATH Shares Outstanding CAGR:1Y: -3.76%2Y: -3.76%5Y: 0.19%10Y: 0.00%
PATH - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
PATH Share Buybacks CAGR:1Y: 7.15%2Y: 232.85%5Y: 0.00%10Y: 0.00%
PATH - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
PATH Stock-Based Comp CAGR:1Y: -30.19%2Y: -22.49%5Y: -26.64%10Y: 0.00%
PATH - Expenses
🔓 See the full chart40% off right now · 7-day free trial
PATH Expenses CAGR:1Y: -79.08%2Y: 47.24%5Y: 0.56%10Y: 0.00%
PATH - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
PATH - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
PATH - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
PATH - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
PATH - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
PATH - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
PATH - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
PATH Revenue CAGR:1Y: 17.32%2Y: 11.74%5Y: 17.57%10Y: 0.00%
PATH - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
PATH Revenue CAGR:1Y: 17.32%2Y: 11.74%5Y: 17.57%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

PATH - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
PATH Actual Revenue CAGR:1Y: 17.32%2Y: 11.74%5Y: 17.57%10Y: 0.00%
PATH - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
PATH Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PATH - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
PATH Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PATH - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
PATH Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

PATH - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
PATH Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PATH - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
PATH Gross Profit Margin CAGR:1Y: -1.17%2Y: -1.32%5Y: 1.95%10Y: 0.00%
PATH - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
PATH Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PATH - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
PATH Price To Sales Ratio CAGR:1Y: -29.80%2Y: -36.79%5Y: -42.19%10Y: 0.00%
PATH - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
PATH Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PATH - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
PATH Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

Projected Future Returns & Dividends for PATH

Based on past 5.5-year performance, here are PATH growth metrics:

Share price CAGR of -25.74%
Dividend CAGR of +0%

Using PATH CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

PATH (DRIP)PATH - No DRIP
Current Price$13.43$13.43
Start Shares744.60744.60
Start Value$10,000$10,000
  
After 10 years:
Final Share Count744.60744.60
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$0.69$13.43
Total Dividends$0$0
Final Value$510$10,000

Estimated Future Value + Dividends - PATH

NOTE: Above numbers are our estimate based on PATH's Dividend and Price CAGR over past 5.5 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

UiPath Inc. (PATH) had its IPO on 2021-04-21, and is traded on NYSE stock exchange.

UiPath Inc. delivers a comprehensive automation ecosystem, specializing in Robotic Process Automation (RPA) solutions, with a significant presence in the United States, Romania, and Japan. The company's integrated software suite empowers organizations to design, administer, execute, interact with, evaluate, and oversee their automation initiatives. This robust platform seamlessly blends artificial intelligence with features such as desktop activity recording and in-depth analysis of both human actions and system logs. Through intuitive visualization tools within a centralized portal, users can effectively discover, analyze, and identify processes ripe for automation. It provides low-code development environments, enabling personnel across an organization to create both human-assisted and fully autonomous automations without needing prior programming knowledge. These automation bots can be deployed for interactive use or run independently in the background, leveraging native connectors for integration with common line-of-business applications. UiPath also offers centralized tools for managing, testing, and deploying automations and machine learning models enterprise-wide, and supports the orchestration of complex, long-running processes that coordinate work between robots and humans. Moreover, the platform allows users to track, measure, and forecast automation performance, assisting businesses in ensuring compliance with industry standards. Beyond its core technology, the company provides essential maintenance and support services, along with professional services like training and implementation to facilitate smooth platform adoption. UiPath's diverse clientele includes entities in banking, healthcare, financial services, and government. Founded in 2005, UiPath Inc. maintains its headquarters in New York, New York.

PATH website: https://www.uipath.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF Model — PATH

Value from:
Pay up to today
—
vs current price $13.43
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →